Lancefield and Hare subsequently identified GBS in vaginal swabs

Lancefield and Hare subsequently identified GBS in vaginal swabs in 1935 [2] and in 1938 Fry described three fatal cases in post-partum women [3]. Reports of neonatal disease from GBS were sporadic until the early 1960s when GBS became recognized as a leading cause of early neonatal sepsis in the USA [4]. By the 1970s it had become the dominant pathogen in the early neonatal period [5]. By the early 1980s GBS had become the most common cause of neonatal sepsis and meningitis in a number of developed countries [6], [7] and [8]. In the past five years, GSK-3 assay late-onset (LO) GBS disease has been associated with case reports of transmission via infected breast milk [9]

raising questions about mode of acquisition and transmission of this enteric pathogen and the development of neonatal disease. Although GBS is not just a neonatal disease, the disease incidence and severity is highest during the first 90 days of life. Early onset (EO) GBS disease (disease presenting in the first six days of life) accounts for approximately 60–70% of all GBS disease. GBS serotypes Ia, Ib, II, III

and V are responsible for most EO disease [10] and [11]. In contrast, serotype III predominates in LO disease, which may be acquired perinatally, click here nosocomially or from the community. [12] In the USA EO disease rates have declined from 1.4 per 1000 live births in 1990 [13] to at 0.28 per 1000 live births in 2012 [14] mainly attributed to the implementation of universal screening for GBS rectovaginal colonization in pregnant women and intrapartum antibiotic prophylaxis. However, the incidence of LO disease has remained static at between 0.3 and 0.4 per 1000 births

since 1990 [14]. This amounts to 28,100 cases and 1865 deaths annually in the USA [14]. Although the epidemiology of GBS in resource-rich countries is well documented, its contribution to the burden of neonatal infection in low/middle income countries has proved more difficult to assess. GBS has been reported as the predominant cause of neonatal sepsis in South Africa and Kenya [15], [16] and [17] as well as an important cause of meningitis in Malawi and and Kenya, but Asian studies have reported a much lower incidence [18], [19] and [20]. A recent systematic review reported that the overall incidence of GBS in resource-poor settings ranged between 0 and 3.06 per 1000 live births [21]. GBS colonizes the rectum and vagina, and maternal colonization is a pre-requisite for EO disease and a risk factor for LO [22] and [23]. In resource-rich countries an estimated 20–30% of pregnant women are colonized with GBS [23] and [24], approximately 50% of their babies become colonized and 1% progress to develop invasive disease. EO disease may occur rapidly; signs of sepsis are evident at birth or within 12 h in over 90% of cases (98% within the first 12 h) [12].

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>